These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8610388)

  • 1. Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease.
    Soderberg C; Larsson S; Rozell BL; Sumitran-Karuppan S; Ljungman P; Moller E
    Transplantation; 1996 Feb; 61(4):600-9. PubMed ID: 8610388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients.
    Soderberg C; Sumitran-Karuppan S; Ljungman P; Moller E
    Transplantation; 1996 Feb; 61(4):594-600. PubMed ID: 8610387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031.
    Cuvelier GD; Kariminia A; Fujii H; Aslanian S; Wall D; Goldman F; Grupp SA; Dunn SE; Krailo M; Shapiro LH; Gilman A; Schultz KR
    Bone Marrow Transplant; 2010 Nov; 45(11):1653-7. PubMed ID: 20190833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mechanism for virus-induced autoimmunity in humans.
    Nauclér CS; Larsson S; Möller E
    Immunol Rev; 1996 Aug; 152():175-92. PubMed ID: 8930673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of human cytomegalovirus by human CD13-specific antibodies.
    Giugni TD; Söderberg C; Ham DJ; Bautista RM; Hedlund KO; Möller E; Zaia JA
    J Infect Dis; 1996 May; 173(5):1062-71. PubMed ID: 8627055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease.
    Pastano R; Dell'Agnola C; Bason C; Gigli F; Rabascio C; Puccetti A; Tinazzi E; Cetto G; Peccatori F; Martinelli G; Lunardi C
    Int Immunol; 2012 Sep; 24(9):583-91. PubMed ID: 22773152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Productive cytomegalovirus (CMV) infection exclusively in CD13-positive peripheral blood mononuclear cells from CMV-infected individuals: implications for prevention of CMV transmission.
    Larsson S; Söderberg-Nauclér C; Möller E
    Transplantation; 1998 Feb; 65(3):411-5. PubMed ID: 9484762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease.
    Rahbar A; Boström L; Söderberg-Naucler C
    J Autoimmun; 2006 May; 26(3):155-64. PubMed ID: 16584867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD13/aminopeptidase N and murine cytomegalovirus infection.
    Kasman LM
    Virology; 2005 Mar; 334(1):1-9. PubMed ID: 15749117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
    Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
    Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immunity to cytomegalovirus and chronic graft-versus-host disease.
    Namboodiri AM; Nietert PJ; Wadia PP; Miklos DB; Pandey JP
    Viral Immunol; 2012 Aug; 25(4):338-40. PubMed ID: 22803743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
    Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Tedder TF; Fujimoto M
    Blood; 2013 Apr; 121(16):3274-83. PubMed ID: 23422748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse Activity of IL-17
    Klimczak A; Suchnicki K; Sedzimirska M; Lange A
    Arch Immunol Ther Exp (Warsz); 2019 Oct; 67(5):311-323. PubMed ID: 31177288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
    Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Close association between antibodies to cytoskeletal intermediate filaments, and chronic graft-versus-host disease.
    Tazzari PL; Gobbi M; Zauli D; Tassinari A; Crespi C; Miserocchi F; Dinota A; Bandini G; Ricci P; Tura S
    Transplantation; 1987 Aug; 44(2):234-6. PubMed ID: 3307047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus immunity in allogeneic marrow grafting.
    Gratama JW; Middeldorp JM; Sinnige LG; van der Meer JW; D'Amaro J; Jansen J; Zwaan FE; Brand A; de Gast GC; The TH
    Transplantation; 1985 Nov; 40(5):510-4. PubMed ID: 2997951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimitochondrial antibodies in patients with chronic graft-versus-host disease.
    Siegert W; Stemerowicz R; Hopf U
    Bone Marrow Transplant; 1992 Sep; 10(3):221-7. PubMed ID: 1422476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Martin SJ; Audrain MA; Oksman F; Ecoiffier M; Attal M; Milpied N; Esnault VL
    Bone Marrow Transplant; 1997 Jul; 20(1):45-8. PubMed ID: 9232255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.
    Kuzmina Z; Gounden V; Curtis L; Avila D; Rnp TT; Baruffaldi J; Cowen EW; Naik HB; Hasni SA; Mays JW; Mitchell S; Baird K; Steinberg SM; Pavletic SZ
    Am J Hematol; 2015 Feb; 90(2):114-9. PubMed ID: 25363867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.
    Fujii H; Cuvelier G; She K; Aslanian S; Shimizu H; Kariminia A; Krailo M; Chen Z; McMaster R; Bergman A; Goldman F; Grupp SA; Wall DA; Gilman AL; Schultz KR
    Blood; 2008 Mar; 111(6):3276-85. PubMed ID: 17925486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.